Abnormal myocardial perfusion and risk of heart failure in patients with type 2 diabetes mellitus

Experimental and Clinical Cardiology

Volumn 18, Issue 1, 2013, Pages

  Utrera Lagunas, Marcelo ^a   Orea Tejeda, Arturo ^a   Castillo Martínez, Lilia ^a   Balderas Muñoz, Karla ^a   Keirns Davis, Candace ^b   Espinoza Rosas, Sarahi ^a   Sánchez Ortíz, Néstor Alonso ^a   Olvera Mayorga, Gabriela ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Diabetes mellitus; Heart failure; Myocardial perfusion

Indexed keywords

CHOLESTEROL; DIPYRIDAMOLE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TECHNETIUM 99M;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; DIABETIC PATIENT; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HEART INFARCTION; HEART MUSCLE PERFUSION; HEART SCINTISCANNING; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; PHARMACOLOGIC STRESS TESTING; PREVALENCE; RISK FACTOR; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 84878324997     PISSN: 12056626     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Shichiri M, Kishikawa H, Ohkubo Y, Wake N. Long-term results of the Kumamoto Study on optimal Diabetes control in type 2 diabetic patients. Diabetes Care 2000;23(Suppl 2):B21-B29. (Pubitemid 30185774)
2. Leung AA, Eurich DT, Lamb DA, et al et al. Risk of HF in patients with recent-onset type 2 diabetes: Population-based cohort study. J Cardiac Fail 2009;15:152-7.
3. .MacDonald MR, Petrie MC, Hawkins NM, et al. Diabetes, left ventricular systolic dysfunction, and chronic HF. Eur Heart J 2008;29:1224-40. (Pubitemid 351768135)
4. Bertoni G, Hundley G, Massing M, Bonds D, Burke G, Goff D. HF prevalence, incidence, and mortality in the elderly with diabetes. Diabetes Care 2004;27:699-703. (Pubitemid 38280536)
5. Nichols GA, Hillier TA, Erbey JR, Brown JB. Congestive HF in type 2 diabetes: Prevalence, incidence, and risk factors. Diabetes Care 2001;24:1614-9. (Pubitemid 33716458)
6. Nichols GA, Guillion ChM, Koro CE, Ephross SA, Brown JB. The incidence of congestive HF in type 2 diabetes. Diabetes Care 2004;27:1879-84.
7. Bio-Tech Systems Inc. Can SPECT-CT revitalize nuclear medicine? Bio-Tech Systems Journal 23, 2008.
8. Marshall RC, Tillisch JH, Phelps ME, et al. Identification of resting myocardial ischemia and infarction in man with positron computed tomography, 18F-labeled fluorodeoxyglucose and N-13 ammonia. Circulation 1983;67:766-78. (Pubitemid 13161454)
9. Arnold JM, Massie BM, Baker DW, et al. HFSA 2006 Comprehensive HF Practice Guideline. J Card Fail 2006;12:e1-e122. (Pubitemid 43267757)
10. Scognamiglio R, Negut C, De Kreutzenberg SV, Tiengo A, Avogaro A. Postprandial myocardial perfusion in healthy subjects and in type 2 diabetic patients. Circulation 2010;112:179-84. (Pubitemid 40982299)
11. Rauchhaus M, Clark AL, Wolfram, et al. The relationship between cholesterol and survival in patients with chronic HF. J Am Coll Cardiol 2003;42:1933-40. (Pubitemid 37485568)
12. Das SR, Drazner MH, Yancy CW, Stevenson LW, Gersh BJ, Dries DL. Effects of diabetes mellitus and ischemic heart disease on the progression from asymptomatic left ventricular dysfunction to symptomatic HF: A retrospective analysis from the Studies of Left Ventricular Dysfunction Prevention Trial. Am Heart J 2004;148:883-8.
13. Abraira C, Colwell JA, Nuttall FQ, et al. Cardiovascular events and correlates in the Veterans Affairs Diabetes Feasibility Trial. Arch Int Med 1997;157:181-8.
14. Stratton IM, Adler AI. Association of glycemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35). Prospective observational study. BMJ 2000;321:405-12. (Pubitemid 30609442)